History of pancreatitis or triglycerides \>=500 mg/dL

Medullary carcinoma or multiple endocrine neoplasia (MEN2) or a family history of either

Active cardiovascular disease

Presence of congestive heart failure

Liver disease

History of severe gastrointestinal diseases

Repeated severe hypoglycemia within the last 6 months

Any previous use of exenatide or other glucagon-like peptide-1 (GLP-1 ) analog

Dipeptidyl peptidase-4 (DPP-4) inhibitor use in the last 3 months

Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes